Bioinformatics and cell reprogramming to develop an in vitro platform to discover new drugs for progressive multiple sclerosis (BRAVEinMS)

Project

Overview

Contributors

EBERINI IVANO   Scientific Manager  

Departments involved

Type

INTLI - Finanziamenti internazionali

Funder

NATIONAL MULTIPLE SCLEROSIS SOCIETY
External Organization Funding Organization

Date/time interval

October 1, 2017 - September 30, 2021

Project duration

48 months

Contacts

Web site